Reversible disruption of XPO1-mediated nuclear export inhibits respiratory syncytial virus (RSV) replication
Abstract Respiratory syncytial virus (RSV) is the primary cause of serious lower respiratory tract disease in infants, young children, the elderly and immunocompromised individuals. Therapy for RSV infections is limited to high risk infants and there are no safe and efficacious vaccines. Matrix (M)...
Enregistré dans:
Auteurs principaux: | Cynthia Mathew, Sharon Tamir, Ralph A. Tripp, Reena Ghildyal |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/010a40d4f4ac4e098a1bb5e948447db9 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Forward and reverse translational approaches to predict efficacy of neutralizing respiratory syncytial virus (RSV) antibody prophylaxis
par: Brian M. Maas, et autres
Publié: (2021) -
Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants
par: Asunción Mejías, et autres
Publié: (2008) -
Factors Associated with Severe Lower Respiratory Tract Infection from Respiratory Syncytial Virus (RSV) in Thai Children
par: Atipotsawee Tungsupreechameth, et autres
Publié: (2021) -
Inhibition of XPO-1 Mediated Nuclear Export through the Michael-Acceptor Character of Chalcones
par: Marta Gargantilla, et autres
Publié: (2021) -
Seasonality, molecular epidemiology, and virulence of Respiratory Syncytial Virus (RSV): A perspective into the Brazilian Influenza Surveillance Program.
par: Lucas A Vianna, et autres
Publié: (2021)